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Prolonging Kidney Graft Survival with Concanavalin A:
Effects of temperature, perfusate composition, pH, and different manufacturing lots
Luis H. Toledo-Pereyra, MD, PhD* and Richard L. Simmons, MD**

This study analyzes the effect of temperature, perfusate
composition, pH, and variable manufacturing lots in prolonging kidney allograft survival with Concanavalin A (Con
A). Cold temperature (4°C), crystalloid composition of the
perfusates, and neutral or mildly alkaline pH were important factors in the effect of Con A on prolonging allograft
survival. Also, different lots of Con A from the same manufacturer produced variable results in prolonging survival.
Thus, multiple factors should be considered if Con A is to be
used to prolong kidney allograft survival.

r ROLONGED allograft survival has been achieved mainly
by suppression of the recipient's immune response. Few
studies have been concerned with prolonging graft survival
by inducing modification of the antigenicity or immunogenicity of allografts. Treatment of allografts in vitro with
c o r t i c o i d s , ' t h a l i d o m i d e , ^ urethane," radiation,^ or
electrophoresis^'^ have prolonged the survival of some
allografts to a greater degree than systemic administrationof
these same agents. In vitro treatment of grafts with streptokinase-streptodornase," ribonucleic acid,'or with purified
recipient transplantation antigens'" does not prolong survival as well as pharmacological manipulations. Minimal or
no immune reaction has been observed toward allografts
treated in vitro with formalin, cyanide'^ or by freeze drying.'" Even these efforts to alter allograft immunogenicity
have used test systems involving normal, unmodified recipients. Such experimental systems are probably capable of
detecting only the most profound alterations in graft immunogenicity, some of which may even lead to loss of graft
viability'^-'"
We have developed a standard system for minimal immunosuppression in dogs which itself is insufficient to prolong
renal allografts. But, in the modified recipient, prolongation
of graft survival by in vitro manipulation can readily be
observed. For example, modification of renal allograft by
perfusion in vitro w i t h heterologous a n t i l y m p h o c y t e
globulin, dipyridamole, phytohemagglutinin, or with Concanavalin A (Con A) will significantly prolong graft function
and life in minimally immunosuppressed dogs,"""
Our best results have been obtained when dog kidney
allografts were perfused in vitro at 4°C with 25 m g / L of Con
A before transplantation. While ultimate rejection always
occurred, dog allografts occasionally survived for as long as
60 days. The doses of azathioprine used were not sufficient
to produce prolonged survival of the kidney graft by itself.
Similarly, perfusion of kidneys with optimal concentration
of Con A had no effect on dogs who did not receive some
systemic immunosuppression."
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In our initial experiments, perfusion of canine kidneys with
Con A did not prolong the survival of transplanted dogs ifthe
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perfusion in vitro was performed at25°C ratherthan at4°C.'''
We hypothesized that Con A became clustered on the fluid
membrane ofthe graft endothelium at the warmer temperature ""^' so that antigen masking was incomplete. In contrast, at4°Cthe fluid cell membrane may have been in a gellike state,''"^'^ which would al low the Con A to become more
evenly diffused over the entire suface, thereby masking the
evenly dispersed histocompatibility antigens. We further
hypothesized that by placing the graft suddenly into the
blood stream at 37°C immediately after transplantation, the
proteins of blood became bound to the excess evenly
distributed Con A on the endothelial membrane so that the
antigen-masking effect was augmented." The present studies are an unsuccessful attemptto verify these hypotheses by
experimental testing.

Excluded from analysis were five dogs that died in the first
three days after transplantation from distemper, postoperative hemorrhage, or anesthetic complications.

Our work also investigates other important factors in prolonging kidney allograft survival wfth Con A, such as pH of
the solution and the manufacturing lot of Con A used. This
last factor is of considerable importance, particularly in
view of recent findings on the rat m o d e l , w h i c h were not
able to reproduce earlier results in prolonging kidney allograft survival with Con A . "

One more set of twenty mongrel dogs was divided into four
groups of five dogs each: Group Xll as the control without
Con A inthe perfusate; Group Xlll transplanted with kidneys
flushed with Con A, 25 mg/L (Lot 330307-NaCI, Cal
Biochem Labs); Group XIV with the same concentration of
Con A but a different lot (Lot 610049-NaCl, Cal Biochem
Labs), and Group XV using kidneys flushed with purified
Con A (Lot 610049-NaCl, Fraction 11*).

Experiment 2
Twenty-two mongrel dogs were divided into four groups:
Group Vlll (n=5) without Con A in the perfusate, and
Groups IX {n = 5), X (n = 6), and XI (n = 6) with 25 m g / L of
Con A (Lot 210073 Cal Biochem Labs, San Diego, CA) inthe
perfusate, maintained at pH 5.6, 6.5, and 7.6, respectively.
The pH was raised from 6.5 to 7.6 in the Ringer's solution
with NaHC03 0.1 N, and HCI 0.1 N was used to obtain a pH
of 5.6.
Experiment 3

Material and Methods
Results

Experiment 1

The survival of the recipients of all renal allografts is
summarized in Figures 1-5. Dogs given normal kidneys
rejected them in two weeks despite being immunosuppressed with azathioprine. Dogs transplanted with kidneys
perfused with Con A in Ringer's lactate at 4°C survived for
prolonged periods, while those which received Con A in
plasma at 4°C did not (Figure 1),

Forty-two adult mongrel dogs of either sex were randomly
divided into seven groups of six dogs each. The dogs were
nephrectomized and given heterotopically unrelated kidneys by standard operative techniques.'^'" After transplantation, 20 mg of furosemide were given intravenously, and
all recipient dogs were given azathioprine 5.0 m g / k g / d a y
intravenously for three days, then 2.5 m g / k g / d a y orally
until death. Serum creatinine was recorded daily The onset
of rejection was defined as the day on which the creatinine
was elevated above 2.0 mg%.

In Groups IV-VII the kidneys treated at 4°C with Con A were
immediately reperfused with 50 ml of plasma or Ringer's
lactate. The prolonged survival of kidneys perfused at 4°C
with Con A was negated by plasma perfused at 4°C or 37°C
(Figure 2). Similar negation of prolonged survival of the
altered kidneys occurred when 50 ml of Ringer's solution at
37°C were passed through the Con A-treated kidney (Figure
3).

Immediately after donor nephrectomy, the kidneys were
flushed from a height of four feet (120 cm/water pressure)
with 500 ml of Ringer's lactate solution (pH 6.5, 4°C,
procaine 0.1 gm/L, heparin 10,000 U/L). The kidneys of
Group I were controlled without Con A in the perfusate,
while those in Group II were flushed wfth Ringer's and Con
A* (25 g/ ml). The kidneys in Group III were flushed at 4°C
with 500 ml of regular canine, normal pooled plasma
containing 25 mg/L of Con A but neither procaine nor
heparin. The kidneys from Groups IV to Vll were first
perfused with Ringer's lactate (500 ml) and Con A (25
mg/ L), and then a second time with 50 ml of either plasma at
4°C (Group IV), Ringer's lactate at 4°C (Group V), Ringer's
lactate at 37°C (Group VI), or plasma at 37°C (Group Vll),

Figure 4 shows the effect of pH on prolonging the survival of
kidneys pretreated with Con A. The best results were
obtained at pH 7.6. Figure 5 shows the effect of various lots
of Con A in prolonging graft survival. While the original lots
330307 and 610049 had no significant effect on prolonging
kidney survival, the purified Con A (Fraction II) did significantly affect the prolongation of kidney survival.
* Fraction II supplied by Cal Biochem Labs (Dr. M.E. Shantz), It was
obtained by passing Con A through a Sephadex-G 50 column and
dialyzing it several times against glucose and NaCl.

* Lot 210073, Cal Biochem Labs, San Diego, CA
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Fig. 1

Fig. 4

Cumulative survival of canine kidney allografts perfused in vitro w i t h
Concanavalin A (Con A) in Ringer's lactate or regular dog plasma. These
data include Groups I, I I , and III.

Cumulative survival of canine kidney allografts perfused in vitro w i t h
Concanavalin A (Con A) in Ringer's lactate (4°C) at different pH levels.
These data include Groups V l l l , IX, X, X I .
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Fig. 2

Fig. 5

Cumulative survival of canine kidney allografts perfused in vitro w i t h
Concanavalin A (Con A) in Ringer's lactate and reperfused w i t h regular
dog plasma at 4°C or 37°C. These data include Groups I, I I , IV, and V l l .

Cumulative survival of canine kidney allografts perfused in vitro w i t h
Concanavalin A (Con A) in Ringer's lactate at 4°C. The effect of various
lots of Con A was tested. These data include Groups X l l , X l l l , XIV, XV.

Discussion
These experiments confirm our previous findings that canine renal allograft survival can be prolonged in minimally
immunosuppressed recipients ifthe kidney is perfused with
Con A in Ringer's lactate at 4 ° C . " On the other hand,
perfusion of kidneys with Con A in plasma at 4°C did not
prolong the survival of dog kidney allografts. Plasma perfusion of the kidney even after modification with Con A in
Ringer's solution at 4°C totally negated the prolongation. Itis
likely that the glycoproteins in plasma remove the Con A
from its exposed position on the endothelium ofthe grafted
kidney. In fact, perfusion with Ringer's solution at 37°C and
to a lesser degree at 4°C reduces the graft modification
initially obtained by perfusion with Con A at 4°C. These
results shed some light on the mechanism by which Con A
modifies the immunogenicity of renal allografts. Modification is obviously temperature dependent and can be
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Fig. 3
Cumulative survival of canine kidney allografts perfused in vitro w i t h
Concanavalin A (Con A) in Ringer's lactate and reperfused w i t h Ringer's at
4°C or 37°C. These data include Groups I, I I , V, and V i .
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achieved only in the cold, although the exact optimal
temperature is still unknown. The Con A is only loosely
bound and can be effectively removed by plasma, presumably because of the high concentration of competitive Con Abinding glycoproteins in plasma. It can even be partially
removed by small volumes of Ringer's perfusate at 4°C,
although ft is much more easily removed at the warmer
temperature. It was previously considered that Con A, which
is itself an immunosuppressive agent, acts synergistically
with azathioprine to systemically immunosuppress the recipient dogs. We found, however, that systemic administration of Con A with azathioprine could not prolong the
survival of unmodified kidney allografts."

Finally, our experiments show that ft is important to control
the manufacturing lot of Con A used in order to achieve
consistent results in modifyinggraft immunogenicity. Recent
lots of Con A (1976-77) have produced more variable results
than were obtained with the original lots used when these
experiments began in 1973. Our recent experience indicates that unless Con A isfurther purified (Fraction II), it does
not prolong graft survival. These results may explain the
difficulties that other investigators encountered in demonstrating prolonged survival in the rat model.^^'" Further
studies in our laboratories are investigating the effect of
endotoxin on the Con A samples as the possible reason for
the lack of consistency obtained by other researchers.^^'^^

Nevertheless, a serious question remains. How is it possible
for Con A to effectively modify graft immunogenicity at the
same temperatures in vivo that remove it most easily in
vftro? One possibility is that Con A on graft endothelium
activates i m m u n o l o g i c a l l y c o m p e t e n t cells that f l o w
through the graft in the first few minutes after grafting. Since
it is known^" that Con A can transform T-cells nonspecifically, it is possible that it retains this mitogenic
potential when it binds to cell membranes. Moreover, the
known capacity of Con A to stimulate suppressive T-cells
may in some way be augmented by attachment to the cell
membrane.'^
Our studies also indicate that Con A in a neutral or slightly
alkaline Ringer's solution had amore pronounced effect on
determining prolongation of kidney allograft survival than in
an acid Ringer's solution. Flushing the kidney with Con A at
a lower pH (5.6) did not prolong survival as well as in the
previous groups. So and Goldstein^'^ have already demonstrated that the binding of Con A to methyl-a-D-mannopyranoside is pH dependent and was maximal at pH 6.2.
Our in vivo studies indirectly confirmed their observations
that very low or high pH reduced the maximal binding
properties of Con A.
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